Peripheral muscle function and body composition in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: a cross-sectional single-centre study
Peripheral muscle function and body composition in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: a cross-sectional single-centre study
Background: people with cystic fibrosis (pwCF) often have multifactorial peripheral muscle abnormalities attributed to, for example, malnutrition, steroid use, altered redox balance and, potentially, CF-specific intrinsic alterations. Malnutrition in CF now includes an increasing prevalence of overweight and obesity, particularly in those receiving CF transmembrane conductance regulator (CFTR) modulator therapy (CFTRm). We aimed to characterise peripheral muscle function and body composition in pwCF on Elexacaftor/Tezacaftor/Ivacaftor (ETI) CFTRm, compared to healthy controls.
Methods: fifteen pwCF on ETI, and 15 healthy age- and sex-matched controls (CON), underwent whole-body dual-energy X-ray absorptiometry scans, and a comprehensive evaluation of peripheral muscle function. Tests included quadriceps maximal isometric force measurement, an intermittent isometric quadriceps fatiguing protocol, handgrip strength dynamometry, squat jump height assessment, and 1-min sit-to-stand testing.
Results: no significant differences in quadriceps maximal isometric force (CON: 181.60 ± 92.90 Nm vs. CF: 146.15 ± 52.48 Nm, p = 0.21, d = 0.47), handgrip strength (CON: 34 ± 15 kg vs. CF: 31 ± 11 kg, p = 0.62, d = 0.18), peripheral muscle endurance, fatigue, or power were observed between the groups. Moreover, no significant differences in whole-body, trunk or limb lean mass, fat-free mass, fat mass, or whole-body bone mineral density were evident.
Conclusions: comparable peripheral muscle mass and function has been demonstrated in pwCF on ETI, albeit a group with good lung function. Research is needed to confirm these findings longitudinally in pwCF, including those with more severe lung disease, who are less physically active, and have less optimal nutrition and exercise support.
cystic fibrosis transmembrane conductance regulator, modulator, muscle strength, obesity, skeletal muscle
Clayton, Lauren J.
d3fedf11-ad8b-4a82-8fc8-47928c519004
Shepherd, Anthony I.
d84a5493-99f5-443b-8b99-4530eb862927
Corbett, Jo
247e073c-a0e2-41f9-8e81-e46214a5a815
Gruet, Mathieu
402f41a1-c8a1-4bee-99eb-4f6d1bfe17e2
Connett, Gary
55d5676c-90d8-46bf-a508-62eded276516
Allenby, Mark
77a723cc-93e7-4ea2-80f1-40664e5207f4
Legg, Julian
2d126c79-30b9-4feb-bec6-aa5de3f0a474
Daniels, Thomas
d635a2fb-96a1-46ec-8cdf-8eb44a4bd0f5
Urquhart, Don S.
74f27c2b-32d0-4bcb-9498-7ee6032f1755
Saynor, Zoe L.
a4357c7d-db59-4fa5-b24f-58d2f7e74e39
12 March 2025
Clayton, Lauren J.
d3fedf11-ad8b-4a82-8fc8-47928c519004
Shepherd, Anthony I.
d84a5493-99f5-443b-8b99-4530eb862927
Corbett, Jo
247e073c-a0e2-41f9-8e81-e46214a5a815
Gruet, Mathieu
402f41a1-c8a1-4bee-99eb-4f6d1bfe17e2
Connett, Gary
55d5676c-90d8-46bf-a508-62eded276516
Allenby, Mark
77a723cc-93e7-4ea2-80f1-40664e5207f4
Legg, Julian
2d126c79-30b9-4feb-bec6-aa5de3f0a474
Daniels, Thomas
d635a2fb-96a1-46ec-8cdf-8eb44a4bd0f5
Urquhart, Don S.
74f27c2b-32d0-4bcb-9498-7ee6032f1755
Saynor, Zoe L.
a4357c7d-db59-4fa5-b24f-58d2f7e74e39
Clayton, Lauren J., Shepherd, Anthony I., Corbett, Jo, Gruet, Mathieu, Connett, Gary, Allenby, Mark, Legg, Julian, Daniels, Thomas, Urquhart, Don S. and Saynor, Zoe L.
(2025)
Peripheral muscle function and body composition in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: a cross-sectional single-centre study.
Pediatric Pulmonology, 60 (3), [e71044].
(doi:10.1002/ppul.71044).
Abstract
Background: people with cystic fibrosis (pwCF) often have multifactorial peripheral muscle abnormalities attributed to, for example, malnutrition, steroid use, altered redox balance and, potentially, CF-specific intrinsic alterations. Malnutrition in CF now includes an increasing prevalence of overweight and obesity, particularly in those receiving CF transmembrane conductance regulator (CFTR) modulator therapy (CFTRm). We aimed to characterise peripheral muscle function and body composition in pwCF on Elexacaftor/Tezacaftor/Ivacaftor (ETI) CFTRm, compared to healthy controls.
Methods: fifteen pwCF on ETI, and 15 healthy age- and sex-matched controls (CON), underwent whole-body dual-energy X-ray absorptiometry scans, and a comprehensive evaluation of peripheral muscle function. Tests included quadriceps maximal isometric force measurement, an intermittent isometric quadriceps fatiguing protocol, handgrip strength dynamometry, squat jump height assessment, and 1-min sit-to-stand testing.
Results: no significant differences in quadriceps maximal isometric force (CON: 181.60 ± 92.90 Nm vs. CF: 146.15 ± 52.48 Nm, p = 0.21, d = 0.47), handgrip strength (CON: 34 ± 15 kg vs. CF: 31 ± 11 kg, p = 0.62, d = 0.18), peripheral muscle endurance, fatigue, or power were observed between the groups. Moreover, no significant differences in whole-body, trunk or limb lean mass, fat-free mass, fat mass, or whole-body bone mineral density were evident.
Conclusions: comparable peripheral muscle mass and function has been demonstrated in pwCF on ETI, albeit a group with good lung function. Research is needed to confirm these findings longitudinally in pwCF, including those with more severe lung disease, who are less physically active, and have less optimal nutrition and exercise support.
Text
Pediatric Pulmonology - 2025 - Clayton - Peripheral Muscle Function and Body Composition in People With Cystic Fibrosis on
- Version of Record
More information
Accepted/In Press date: 3 March 2025
Published date: 12 March 2025
Keywords:
cystic fibrosis transmembrane conductance regulator, modulator, muscle strength, obesity, skeletal muscle
Identifiers
Local EPrints ID: 499759
URI: http://eprints.soton.ac.uk/id/eprint/499759
ISSN: 8755-6863
PURE UUID: 4c5d9973-2021-4f0b-ac3d-3931c07d69db
Catalogue record
Date deposited: 03 Apr 2025 16:35
Last modified: 11 Sep 2025 03:41
Export record
Altmetrics
Contributors
Author:
Lauren J. Clayton
Author:
Anthony I. Shepherd
Author:
Jo Corbett
Author:
Mathieu Gruet
Author:
Gary Connett
Author:
Mark Allenby
Author:
Julian Legg
Author:
Thomas Daniels
Author:
Don S. Urquhart
Author:
Zoe L. Saynor
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics